Microarray technology has become one of the principal platform technologies for the high-throughput analysis of biological systems.[1] Starting with the evolution of DNA microarrays in the 1990s, the developments of peptide and protein microarrays to elucidate interaction partners, modification sites, and enzyme substrates, [2,3] this technology is nowadays moving towards the construction of microarrays of fixed-tissue samples [4] and live cells. [5] The latter are expected to help unravel complex cellular traits in both healthy and diseased states because cell microarrays provide the ability to molecularly delineate the characteristics of individual cells from complex mixtures. By immobilizing different cellcapture and analysis reagents on a solid support, mixtures of cells can be rapidly interrogated for their composition and phenotype, thus helping to identify and quantitate distinct cell types based on the expression of particular cell-surface molecules. Furthermore, this immobilization helps to analyze the response of different cell types to defined signals through the secretion of specific factors or other measurable cellular activities. [5] To immobilize cell-capture moieties on suitable solid supports, proteins, peptides, or other ligands are usually attached to surfaces by using covalent coupling, chemisorption, or physisorption processes in combination with robotic spotting procedures. [1,5,6] Motivated by the extraordinary performance of the DNA-directed immobilization (DDI) of proteins and other molecular and colloidal components, [7] we herein describe that micropatterns of cell-surface ligands can be generated on DNA microarrays by the DDI method and that the resulting surfaces are suitable substrates for the growth of fibroblast cells (Figure 1). This approach should have significant advantages over conventional spotting procedures because it would enable the implementation of the power of DNA microarrays as decoding tools in combinatorial synthesis and screening of ligands [8] into cellular biology research. To experimentally investigate this hypothesis, we chose the well-studied recognition of RGD peptide ligands by integrin surface receptors of fibroblast cells as the model system. [9][10][11] As depicted in Figure 1, covalent conjugates of streptavidin (STV) and single-stranded DNA (ssDNA), were used as molecular adaptors in the DNA-directed immobilization of biotinylated peptides. To this end, three different DNA-STV conjugates (F1, F5, F10, shown schematically in Figure 1) containing the 22-mer oligonucleotides tF1, tF5, and tF10, respectively, were prepared as previously described. [12,13] In separate reaction tubes, conjugates F1 and F5 were then coupled with one molar equivalent of the biotinylated peptide bRGDF (biotin-Gly 5 -Arg-Gly-Asp-Phe-COOH), [10] and, as a control, bG5 (biotin-Gly 5 -COOH), thus leading to conjugates F1-bRGDF and F5-bG5, respectively. To allow for visualization of the immobilized conjugates by fluorescence analysis, five molar equivalents of biotinylated fluorescen...